Altimmune Stock Technical Analysis
| ALT Stock | USD 6.91 0.02 0.29% |
As of the 20th of April, Altimmune shows the Standard Deviation of 7.28, risk adjusted performance of (0.03), and Mean Deviation of 5.18. Altimmune technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate thirteen technical drivers for Altimmune, which can be compared to its peers. Please confirm Altimmune market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Altimmune is priced correctly, providing market reflects its regular price of 6.91 per share. Given that Altimmune has information ratio of (0.08), we suggest you to validate Altimmune's prevailing market performance to make sure the company can sustain itself at a future point.
Altimmune Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Altimmune, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AltimmuneAltimmune |
Altimmune Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 19.38 | Strong Buy | 8 | Odds |
Most Altimmune analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Altimmune stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Altimmune, talking to its executives and customers, or listening to Altimmune conference calls.
Altimmune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Altimmune Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Altimmune volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Altimmune Trend Analysis
Use this graph to draw trend lines for Altimmune. You can use it to identify possible trend reversals for Altimmune as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Altimmune price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Altimmune Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Altimmune applied against its price change over selected period. The best fit line has a slop of 0.04 , which may imply that the returns on investment in Altimmune will continue to fail. It has 122 observation points and a regression sum of squares at 51.83, which is the sum of squared deviations for the predicted Altimmune price change compared to its average price change.About Altimmune Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Altimmune on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Altimmune based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Altimmune price pattern first instead of the macroeconomic environment surrounding Altimmune. By analyzing Altimmune's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Altimmune's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Altimmune specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | PTB Ratio | 3.09 | 3.24 | Dividend Yield | 0.42 | 0.4 |
Altimmune April 20, 2024 Technical Indicators
Most technical analysis of Altimmune help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Altimmune from various momentum indicators to cycle indicators. When you analyze Altimmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 5.18 | |||
| Coefficient Of Variation | (1,549) | |||
| Standard Deviation | 7.28 | |||
| Variance | 53.06 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.78) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 34.98 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 13.31 | |||
| Skewness | 0.8604 | |||
| Kurtosis | 2.14 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Altimmune Stock analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Altimmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altimmune. If investors know Altimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.66) | Revenue Per Share 0.008 | Quarterly Revenue Growth 180 | Return On Assets (0.25) | Return On Equity (0.47) |
The market value of Altimmune is measured differently than its book value, which is the value of Altimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Altimmune's value that differs from its market value or its book value, called intrinsic value, which is Altimmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altimmune's market value can be influenced by many factors that don't directly affect Altimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Altimmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altimmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.